Efficacy of the Hemoperfusion Therapy in Patients with Severe COVID-19-Associated Pneumonia: An Experience from Single-center Observational Study

Recruiting

• Conditions: Severe COVID-19-associated pneumonia with or without hemoperfusion therapy; Hemoperfusion, adsorption therapy, COVID-19, Pneumonia, Acute respiratory distress syndrome, Critical care, SARS-CoV2, cytokine storm, blood purification

• Registration Number: TCTR20210627002
• Lead Sponsor: Faculty of Medicine, Chiang Mai University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-06-27
• Study Completion: 2021-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

1. Age >18 years, 2. Severe COVID-19-associated pneumonia with or without hemoperfusion therapy, 3. Admitted in Chiang Mai University Hospital, Chiang Mai, Thailand

Exclusion Criteria

No

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cytokine levels Before and after hemoperfusion ELISA kit

Secondary Outcome Measures

Name	Time	Method
SOFA score Before and after hemoperfusion Lab parameter